Thursday, September 28, 2023 11:10:20 AM
TORONTO, ONTARIO, September 28th, 2023, - Appia Rare Earths & Uranium Corp. (the “Company” or “Appia”) (CSE: API) (OTCQX: APAAF) (Germany: “A0I0.F”, “A0I0.MU”, “A0I0.BE”) is pleased to provide an update on the progress of its ongoing drilling program to outline the extent of the mineralized zone at Target IV on its PCH Iconic Clay Project in Brazil. To date, the Company has processed and sent 2,255 samples for analysis, from both the Reverse Circulation (RC) and Auger drill programs, and expects to release results in the near future.
Summary:
Completed 232 drill holes for a total of 2847.5 metres, of which:
Reverse Circulation drilling: 147 holes totaling of 2,019 metres.
Auger drilling: 84 holes totalling of 585 metres.
Diamond drilling - Completion of 243.50 metres.
Logging and sampling is ongoing, and currently, 2,255 samples have been sent to SGS Geosol laboratory for assaying.
“The reverse circulation (RC) drilling has averaged roughly 13 metres depth, often exceeding 20 metres depth and encountering clayey materials in the majority of holes. Auger sampling, on the other hand, has an average depth of about 7 metres, with samples collected every meter,” stated Carlos Bastos, Geology Manager and Brazilian QP. “And in specific cases, alternative methodologies have been applied to gain a deeper understanding of the mineralized zones and analytical methods.”
He continued, "With diamond, RC, and auger drilling activities running concurrently, the project has made substantial advancements. Our team is exceptionally pleased with the productivity, geological insights, and interpretation we have gathered thus far. We are confident that the forthcoming results from the SGS laboratory will strengthen our belief that we are positioned within a significant rare earth element ionic clay deposit."
Read more and view graphics at:
https://www.appiareu.com/news/appia-provides-update-on-its-extensive-drilling-program-at-its-pch-ionic-clay-project-brazil
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM